BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 16492214)

  • 1. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
    Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
    Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma: prevalence and cost of illness.
    Stock S; Redaelli M; Luengen M; Wendland G; Civello D; Lauterbach KW
    Eur Respir J; 2005 Jan; 25(1):47-53. PubMed ID: 15640322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
    Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
    J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hesse/KV in Hesse].
    Hauner H; Köster I; von Ferber L
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2632-7. PubMed ID: 14673738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007.
    Köster I; Huppertz E; Hauner H; Schubert I
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):377-85. PubMed ID: 21264804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient costs of osteoporosis in a national health insurance population.
    Krappweis J; Rentsch A; Schwarz UI; Krobot KJ; Kirch W
    Clin Ther; 1999 Nov; 21(11):2001-14. PubMed ID: 10890269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany.
    Zeidler J; Mittendorf T; Vahldiek G; Zeidler H; Merkesdal S
    Rheumatology (Oxford); 2008 Oct; 47(10):1527-34. PubMed ID: 18682412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Longitudinal analysis of utilization of inpatient treatment based on insurance data of mandatory health insurance].
    Dörning H; Bitzer EM; Hofmann W; Schwartz FW
    Gesundheitswesen; 1995 Oct; 57(10):631-7. PubMed ID: 8527879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of paediatric diabetes care in Germany: current situation and comparison with the year 2000.
    Bächle CC; Holl RW; Straßburger K; Molz E; Chernyak N; Beyer P; Schimmel U; Rütschle H; Seidel J; Lepler R; Holder M; Rosenbauer J; Icks A; ;
    Diabet Med; 2012 Oct; 29(10):1327-34. PubMed ID: 22417295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Costs of type 2 diabetes in Germany. Results of the CODE-2 study].
    Liebl A; Neiss A; Spannheimer A; Reitberger U; Wagner T; Görtz A
    Dtsch Med Wochenschr; 2001 May; 126(20):585-9. PubMed ID: 11402924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A cost of illness study of diabetes mellitus].
    von Ferber L; Köster I; Hauner H
    Gesundheitswesen; 1997 Jan; 59(1):17-22. PubMed ID: 9138642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term health insurance payments for depression in Germany - a secondary analysis of routine data].
    Stamm K; Reinhard I; Salize HJ
    Neuropsychiatr; 2010; 24(2):99-107. PubMed ID: 20605005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The costs of diabetes mellitus and its complications in Germany].
    Hauner H
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S240-2. PubMed ID: 17139578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental prescription and drug costs during the years preceding diabetes diagnosis in primary care practices in Germany.
    Icks A; Haastert B; Giani G; Rathmann W
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):348-55. PubMed ID: 16915536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes 'epidemic' in Germany? A critical look at health insurance data sources.
    Hoffmann F; Icks A
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):410-5. PubMed ID: 22441721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of illness of malignant lymphoma in Germany.
    Reis A; Ihle P; Paulus U; Ferber LV; Diehl V; Walshe R
    Eur J Cancer Care (Engl); 2006 Sep; 15(4):379-85. PubMed ID: 16968321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.